Lola Koktysh[email protected]MRIQuantitative imaging biomarkers show promise for NASHQuantitative imaging biomarkers are a promising approach for evaluating normal biological or pathogenic processes, as well as response to treatment and intervention. One near-term clinical application is the assessment of nonalcoholic steatohepatitis (NASH), according to Lola Koktysh of ScienceSoft.March 6, 2017Page 1 of 1Top StoriesMolecular ImagingPET reveals ‘smoldering’ brain inflammation in patients treated for MSPET brain scans show persistent brain inflammation in patients with multiple sclerosis (MS), despite being treated with therapies.CTUnderstanding CT flow artifacts is key to better disease diagnosisMolecular ImagingDual-tracer PET/CT shows promise in liver cancer patientsWomens ImagingStudies lacking for trans breast cancer screening trendsSponsor ContentWe care about what you think.